Envestnet Asset Management Inc. Trims Holdings in American Healthcare REIT, Inc. $AHR
Envestnet Asset Management Inc. reduced its stake in American Healthcare REIT, Inc. (NYSE:AHR) by 11.7% in the third quarter, now holding 280,774 shares valued at $11.8 million. Despite this, institutional ownership remains at 16.68%, with other firms like Franklin Resources increasing their positions. Analysts generally maintain a "Moderate Buy" rating for AHR with a consensus price target of $52.00, although director Jeffrey T. Hanson recently sold a significant number of shares.
American Healthcare REIT, Inc. $AHR Shares Sold by Aberdeen Group plc
Aberdeen Group plc reduced its stake in American Healthcare REIT, Inc. (NYSE:AHR) by 19.6% in the third quarter, selling over 262,000 shares. Despite this, other institutional investors have bought new positions or increased their holdings in the company. American Healthcare REIT recently announced a quarterly dividend of $0.25 per share and has an average analyst rating of "Moderate Buy."
Thrivent Financial for Lutherans Makes New $944,000 Investment in American Healthcare REIT, Inc. $AHR
Thrivent Financial for Lutherans initiated a new position in American Healthcare REIT (AHR), acquiring 22,475 shares valued at approximately $944,000 during the third quarter. This investment comes as analysts maintain a "Moderate Buy" consensus rating for AHR with a target price of $51.83, despite a director recently selling a significant portion of his holdings. The company also announced a quarterly dividend, paying $0.25 per share.
Can American Healthcare REIT's (AHR) Interim CEO Appointment Quietly Reinforce Its Long-Term Real Estate Strategy?
American Healthcare REIT (AHR) announced that Chairman Jeffrey T. Hanson has been appointed Interim CEO and President following CEO Danny Prosky's medical leave. This leadership change emphasizes continuity in the company's existing growth-focused strategy, particularly concerning its diversified healthcare real estate portfolio and recent 2025 acquisitions. Investors are now focusing on how consistently the company will execute its acquisition and integration playbook across its expanded portfolio.
Healthcare REIT Posts 16.4% NOI Growth as Shares Soar 93%: Why This Fund's New Stake Stands Out
Neo Ivy Capital Management recently acquired a new stake of 136,925 shares in American Healthcare REIT (NYSE: AHR), valued at an estimated $6.44 million. This investment comes as American Healthcare REIT has shown strong performance, with its shares soaring 93% over the past year and reporting 16.4% same-store Net Operating Income (NOI) growth in the third quarter. The article highlights the REIT's diversified portfolio and its strategy to capitalize on demographic-driven demand for healthcare real estate.
A Look At American Healthcare REIT (AHR) Valuation After Strong Recent Share Returns
American Healthcare REIT (AHR) has shown strong recent share returns, with a 1-year total shareholder return of 86.86%. Despite this, the stock is considered undervalued at $51.70, trading below a fair value of $56.08 based on detailed long-term growth and margin assumptions. The positive outlook is primarily driven by a projected supply-demand imbalance in senior housing, though potential challenges like softer outpatient leasing trends could impact growth.
American Healthcare REIT stock hits all-time high at 51.35 USD
American Healthcare REIT (AHR) stock has reached an all-time high of $51.35, reflecting strong investor confidence and an 87.63% total return over the past year. This milestone occurs despite recent news of CEO Danny Prosky's medical leave, with Jeffrey T. Hanson appointed as interim CEO. Analysts maintain a positive outlook, with BMO Capital and Citizens reiterating Outperform ratings and favorable price targets.
American Healthcare REIT stock hits all-time high at 51.35 USD
American Healthcare REIT (AHR) stock has reached an all-time high of $51.35, signaling strong investor confidence and robust performance over the past year with an 87.63% total return. The company maintains a "GREAT" overall financial health score and analysts have largely positive outlooks, despite recent news of CEO Danny Prosky taking medical leave and the appointment of an interim CEO. AHR recently completed over $950 million in acquisitions in 2025.
American Healthcare REIT (NYSE:AHR) Hits New High in NYSE Composite
American Healthcare REIT (NYSE:AHR) has reached a new high in the NYSE Composite, driven by its diversified healthcare properties, structured leases, and effective operational management. The company manages various healthcare properties including senior housing, skilled nursing, and medical offices across major US markets. This achievement highlights AHR's significant presence and performance within the healthcare real estate sector.
Does American Healthcare REIT's (AHR) Interim CEO Shift Reveal Strength or Strain in Boardroom Governance?
American Healthcare REIT announced that CEO Danny Prosky is on medical leave, with Board Chairman Jeffrey T. Hanson stepping in as Interim CEO and President. This leadership change draws attention to the company's corporate governance and succession planning, particularly given the REIT's focus on income-producing healthcare real estate and recent capital raises. While the market reaction has been mild, the interim appointment highlights potential short-term risks related to leadership uncertainty and existing low interest coverage.
American Healthcare REIT Names Interim CEO During Medical Leave
American Healthcare REIT announced that CEO and President Danny Prosky has taken a medical leave, effective February 3, 2026. Board Chairman Jeffrey T. Hanson will serve as interim CEO and President to ensure operational continuity. The company, which specializes in owning and operating healthcare properties, maintains confidence in its leadership team and strategic objectives despite the temporary change.
American Healthcare REIT stock rating reiterated at Market Outperform by Citizens
Citizens has reiterated its Market Outperform rating and $60.00 price target for American Healthcare REIT (NYSE:AHR) despite CEO Danny Prosky taking a medical leave of absence since February 3rd, 2026. The firm cited the company's strong financial health, impressive stock performance under Prosky's leadership, and favorable market fundamentals in senior housing. Chairman Jeffrey T. Hanson has been appointed interim CEO and President, and Citizens believes it will be "business as usual" for AHR.
American Healthcare REIT stock rating reiterated at Market Outperform by Citizens
Citizens has reiterated its Market Outperform rating and $60.00 price target for American Healthcare REIT (NYSE:AHR), even after CEO Danny Prosky took a medical leave of absence. The research firm believes the company will continue "business as usual" with interim CEO Jeffrey T. Hanson, citing AHR's strong financial health, solid revenue growth, and positive outlook on its senior housing market position. The company has shown impressive performance since its IPO, with a 63.86% return over the past year and significant acquisitions in 2025.
Citizens Jmp Reaffirms Market Outperform Rating for American Healthcare REIT (NYSE:AHR)
Citizens Jmp has reaffirmed its "Market Outperform" rating for American Healthcare REIT (NYSE:AHR), setting a price target of $60, which implies a potential upside of over 25%. AHR has a consensus "Moderate Buy" rating from analysts with an average price target of $51.83. Despite insider selling activity totaling $3.72 million over the last 90 days, institutional investors have increased their holdings, with the stock currently trading near $47.93.
Citizens Reiterates Market Outperform Rating for AHR with $60 PT
Citizens analyst Aaron Hecht has reiterated a 'Market Outperform' rating for American Healthcare REIT (AHR), maintaining a price target of $60.00 USD. This decision reflects continued confidence in the company's financial performance. Other analysts have also expressed a generally positive outlook, with an average target price of $56.08 among 13 analysts, implying a potential upside of 19.77% from its current price.
American Healthcare REIT stock rating reiterated at Market Outperform by Citizens
Citizens has reiterated its Market Outperform rating and $60.00 price target for American Healthcare REIT (AHR) despite CEO Danny Prosky taking a medical leave of absence. The firm believes the company will continue "business as usual" under interim CEO Jeffrey T. Hanson, citing AHR's strong financial health, impressive revenue growth, and strategic acquisitions in 2025. Citizens views AHR as a top healthcare real estate idea due to its FFO growth and favorable senior housing market fundamentals.
American Healthcare REIT Announces Chief Executive Officer and President Danny Prosky to Take Medical Leave of Absence
American Healthcare REIT, Inc. announced that its CEO and President, Danny Prosky, is taking a medical leave of absence due to a recent medical event, effective February 3, 2026. Jeffrey T. Hanson, Chairman of the Board, has been appointed Interim CEO and President to ensure continuity of operations. The company expressed its full support for Mr. Prosky and his family while emphasizing confidence in the senior leadership team.
Chairman steps in as American Healthcare REIT CEO faces medical leave
American Healthcare REIT (NYSE: AHR) announced that CEO and President Danny Prosky has taken a medical leave of absence, effective February 3, 2026, due to a recent medical event. The Board has appointed Jeffrey T. Hanson, the Chairman, as Interim CEO and President to ensure leadership continuity. Hanson will work closely with the senior leadership team to maintain operations and execute strategic priorities during Prosky's absence.
American Healthcare REIT Announces Chief Executive Officer and President Danny Prosky to Take Medical Leave of Absence
American Healthcare REIT, Inc. announced that its Chief Executive Officer and President, Danny Prosky, has taken a medical leave of absence effective February 3, 2026, due to a recent medical event. Jeffrey T. Hanson, Chairman of the Board, has been appointed Interim Chief Executive Officer and President to ensure continuity of operations. The company expressed its full support for Mr. Prosky and confidence in its senior leadership team.
American Healthcare REIT, Inc. (NYSE:AHR) Receives Average Rating of "Moderate Buy" from Analysts
American Healthcare REIT, Inc. (NYSE:AHR) has received a consensus "Moderate Buy" rating from fourteen analysts, with an average 12-month target price of $51.83. Several firms, including Morgan Stanley, RBC, and KeyCorp, have recently raised their price targets. Insider transactions show net selling of 76,288 shares worth approximately $3.72 million in the last three months, though insiders still own about 1.0% of shares.
A4 Wealth Advisors LLC Buys Shares of 53,106 American Healthcare REIT, Inc. $AHR
A4 Wealth Advisors LLC has acquired 53,106 shares of American Healthcare REIT, Inc. (NYSE:AHR) in the third quarter, representing a $2.23 million investment and making it the 12th largest holding in their portfolio. This move comes despite recent insider selling, with Director Jeffrey T. Hanson and EVP Mark E. Foster reducing their stakes. Analysts maintain a "Moderate Buy" consensus rating for AHR, with a price target of $51.83.
Principal Financial Group Inc. Reduces Stake in American Healthcare REIT, Inc. $AHR
Principal Financial Group Inc. reduced its stake in American Healthcare REIT, Inc. (NYSE:AHR) by 8.8% in the third quarter, while other institutional investors made various adjustments to their holdings. Corporate insiders have been net sellers of AHR stock, and the company announced a quarterly dividend of $0.25 per share, yielding 2.1%. Analysts maintain a "Moderate Buy" consensus rating with an average target price of $51.83.
Truist Reduces PT on American Healthcare REIT (AHR) Stock
Truist analyst Michael Lewis reduced the price target on American Healthcare REIT (AHR) stock to $52 from $53, while maintaining a "Buy" rating. This adjustment was part of broader revisions for the real estate investment trust group concerning the 2026 outlook, with Truist being "Neutral" on REITs overall. Despite improving fundamentals in the REIT sector, the analyst believes stocks are not particularly cheap, though the firm remains bullish on certain sectors like healthcare and lodging REITs.
Truist Reduces PT on American Healthcare REIT (AHR) Stock
Truist analyst Michael Lewis reduced the price target for American Healthcare REIT (AHR) to $52 from $53 while maintaining a "Buy" rating. This adjustment is part of a broader review of the real estate investment trust group for 2026, with Truist expressing a "Neutral" stance on REITs overall. Despite improving fundamentals in some sectors, the analyst notes that stocks are not particularly cheap, though the firm remains bullish on healthcare, industrial, strip retail, gaming, and lodging REITs.
BMO Capital Markets Begins Coverage on American Healthcare REIT (NYSE:AHR)
BMO Capital Markets has initiated coverage on American Healthcare REIT (NYSE:AHR) with an "Outperform" rating and a $55 price target, suggesting a 16.5% upside. This new rating aligns with a broader analyst consensus of a "Moderate Buy" for the healthcare-focused REIT. The report also details recent insider selling activities and significant institutional ownership, particularly by Vanguard Group Inc.
Knights of Columbus Asset Advisors LLC Acquires 28,740 Shares of American Healthcare REIT, Inc. $AHR
Knights of Columbus Asset Advisors LLC has increased its stake in American Healthcare REIT (NYSE: AHR) by 27.6%, purchasing 28,740 shares, bringing their total holding to 133,028 shares valued at approximately $5.59 million. Despite this institutional buying, company insiders have sold 76,288 shares worth about $3.72 million in the last quarter. Analysts generally maintain a "Moderate Buy" rating for AHR, with an average target price of $51.83, and several firms have recently raised their price targets.
Federated Hermes Inc. Has $46.71 Million Holdings in American Healthcare REIT, Inc. $AHR
Federated Hermes Inc. significantly increased its stake in American Healthcare REIT, Inc. by 57.2%, now holding over $46.71 million in shares. This comes as insider selling activities were noted, and analysts issued a "Moderate Buy" consensus with an average target price of $51.83 for AHR. The company also declared a quarterly dividend despite a high dividend payout ratio.
Assessing American Healthcare REIT (AHR) Valuation After Strong One Year Return And Recent Price Softness
American Healthcare REIT (AHR) has shown a strong 67.2% one-year return despite recent short-term price softness. The company, trading at US$46.33 against an analyst target of US$56.17 and an intrinsic discount of around 47%, is considered by many to be undervalued. Its strategy of optimizing its portfolio by selling older assets and acquiring modern properties, alongside scalable operating initiatives, is expected to drive future growth in AFFO and earnings.
Assessing American Healthcare REIT (AHR) Valuation After Strong One Year Return And Recent Price Softness
American Healthcare REIT (AHR) has shown a strong 67.2% total return over the past year, despite recent short-term price softness. The REIT, with revenue of US$2.19 billion and net income of US$27.26 million, is currently valued at US$46.33 per share, significantly below an analyst target of US$56.17. Its valuation suggests it is undervalued, driven by expectations of improved asset quality and operational efficiency from portfolio optimization and scalable operating initiatives.
American Healthcare REIT stock initiated with Outperform rating by BMO Capital
BMO Capital initiated coverage on American Healthcare REIT (AHR) with an Outperform rating and a $55 price target, citing expected leading earnings growth from its Trilogy and SHOP exposure. The analyst projects an 18.2% year-over-year increase in 2026 FFO per share, supported by robust demand and strategic acquisitions. Despite a high P/E ratio, the firm believes AHR is well-positioned for accretive external growth, with execution being key to achieving its potential 21% total return.
Truist Financial Lowers American Healthcare REIT (NYSE:AHR) Price Target to $52.00
Truist Financial has reduced its price target for American Healthcare REIT (NYSE:AHR) from $53.00 to $52.00, while maintaining a "buy" rating, indicating a potential upside of 8.20%. Analyst consensus for AHR is a "Moderate Buy" with an average target price of $51.55. Insiders have been net sellers, disposing of 76,288 shares worth approximately $3.72 million over the past 90 days, though they still own 1% of the company.
WPG Advisers LLC Reduces Position in American Healthcare REIT, Inc. $AHR
WPG Advisers LLC significantly reduced its stake in American Healthcare REIT, Inc. (NYSE:AHR) by 71.5% in the third quarter, selling 61,573 shares. Despite this reduction, American Healthcare REIT remains a "Moderate Buy" among analysts, with an average target price of $51.64. The company recently paid a $0.25 quarterly dividend, representing a 2.1% yield, though its high dividend payout ratio of 714.29% raises questions about sustainability.
Sumitomo Mitsui Trust Group Inc. Has $10.32 Million Stock Holdings in American Healthcare REIT, Inc. $AHR
Sumitomo Mitsui Trust Group Inc. reduced its stake in American Healthcare REIT, Inc. by 9.9% in Q3, now holding 245,732 shares worth $10.32 million. Despite this, institutional investors collectively own 16.68% of the stock, with several other firms increasing their positions. Analysts generally rate AHR as a "Moderate Buy" with an average price target of $51.64, though the company's high dividend payout ratio of 714.29% raises concerns about its sustainability.
March 20th Options Now Available For American Healthcare Reit (AHR)
New options contracts for American Healthcare Reit (AHR) with a March 20th expiration date have begun trading. An analysis of a specific call contract at the $50.00 strike price suggests a potential 4.01% return for a covered call strategy if the stock is called away. The article also discusses the probability of the contract expiring worthless and the implied versus trailing twelve-month volatility.
SG Americas Securities LLC Increases Stock Position in American Healthcare REIT, Inc. $AHR
SG Americas Securities LLC significantly increased its stake in American Healthcare REIT (NYSE:AHR) by 645% in Q3, adding 50,529 shares to hold 58,363 shares valued at approximately $2.45 million. Despite insider selling, with Director Jeffrey T. Hanson reducing his holdings by 64.9% and total insider sales reaching $3.72 million in the last 90 days, analysts maintain a "Moderate Buy" consensus and a price target of $51.64. The company has also declared a quarterly dividend of $0.25, amounting to an annualized yield of 2.1%.
American Healthcare REIT (AHR) Beats Q1 FFO and Revenue Estimates
American Healthcare REIT (AHR) announced better-than-expected Q1 funds from operations (FFO) of $0.38 per share, surpassing the Zacks Consensus Estimate of $0.37, and also beat revenue estimates with $540.6 million. Despite outperforming the market year-to-date, the company currently holds a Zacks Rank #4 (Sell) indicating potential underperformance in the near future based on unfavorable estimate revisions. The article also provides upcoming FFO and revenue estimates for AHR and mentions another stock, VersaBank (VBNK), reporting soon.
American Healthcare REIT Bets on Managed Senior Housing for Next Phase of Growth
American Healthcare REIT (NYSE: AHR) is focusing on managed long-term care assets, such as assisted living and skilled nursing, for its future growth, driven by increasing demand from aging baby boomers. CEO Danny Prosky highlights the advantage of operational upside in these managed properties, relying on strong operator relationships. The company anticipates rising competition and more available properties in the senior housing market in 2026 as fundamentals improve.
American Healthcare REIT, Inc. (AHR) Gets a Buy from UBS
UBS analyst Michael Goldsmith maintained a Buy rating on American Healthcare REIT, Inc. (AHR) with a price target of $56.00. This recommendation comes despite negative corporate insider sentiment, with increased insider selling, including a recent sale by director Jeffrey T Hanson. The company reported strong Q3 earnings, with revenue of $572.94 million and a net profit of $55.93 million, significantly improving from a GAAP net loss in the prior year.
American Healthcare REIT, Inc. (NYSE:AHR) Receives Average Recommendation of "Moderate Buy" from Analysts
American Healthcare REIT, Inc. (NYSE:AHR) has received an average "Moderate Buy" rating from fourteen analysts, with a mean 12-month target price of $51.64. Insider selling activity has been noted, with 76,288 shares sold in the last 90 days. The company announced a quarterly dividend of $0.25 (annual $1.00), resulting in a 2.1% yield and an elevated payout ratio of 714.29%.
American Healthcare REIT, Inc. $AHR Shares Sold by Commonwealth Equity Services LLC
Commonwealth Equity Services LLC reduced its stake in American Healthcare REIT (AHR) by 19.2% in Q3 2025, selling 221,901 shares and now holding 934,276 shares valued at $39.25 million. Company insiders also sold a total of 76,288 shares worth approximately $3.72 million in the last three months. Despite a high dividend payout ratio of 714.29%, American Healthcare REIT announced a quarterly dividend of $0.25 per share, yielding 2.1% annually.
American Healthcare REIT Announces Dates for Fourth Quarter 2025 Earnings Release and Conference Call
American Healthcare REIT, Inc. (NYSE: AHR) announced it will release its fourth quarter 2025 earnings on Thursday, February 26, 2026, after market close. A public conference call and webcast will follow on Friday, February 27, 2026, at 10:00 a.m. Pacific Time to review results and discuss recent events. The earnings report and supplemental data will be available on the company's Investor Relations website.
American Healthcare REIT Announces Dates for Fourth Quarter 2025 Earnings Release and Conference Call
American Healthcare REIT, Inc. (NYSE: AHR) has announced that its fourth quarter 2025 earnings release will be issued on Thursday, February 26, 2026, after market close. A public conference call and simultaneous webcast to discuss these results, recent events, and for a Q&A session will take place on Friday, February 27, 2026, at 10:00 a.m. Pacific Time / 1:00 p.m. Eastern Time. Investors can access the webcast or call details through the provided links and numbers.
American Healthcare REIT acquires Talamore Senior Living in Woodbury for $88M
American Healthcare REIT has acquired Talamore Senior Living in Woodbury for $88 million. This acquisition marks another significant investment for the California-based investor, which previously purchased other senior living facilities in Minnetonka, St. Paul, and Bloomington within the past year. The deal highlights continued activity in the senior living real estate market.
American Healthcare REIT (NYSE:AHR) Cut to "Hold" at Zacks Research
Zacks Research has downgraded American Healthcare REIT (NYSE:AHR) from a "strong-buy" to a "hold" rating, despite the stock maintaining a "Moderate Buy" consensus from other analysts with a target of $51.64. The company is currently trading near $47.24 with a high trailing P/E of 337.44, suggesting a stretched valuation. Insider sales totaling $3.72 million over the past 90 days contrast with increased institutional investor stakes, creating mixed ownership signals.
Cwm LLC Sells 103,662 Shares of American Healthcare REIT, Inc. $AHR
Cwm LLC reduced its stake in American Healthcare REIT (NYSE:AHR) by 57.5% in Q3, selling 103,662 shares to hold 76,700 shares valued at $3.22 million. Institutional investors now own approximately 16.68% of the company, while insiders, who have been net sellers, hold about 0.92%. Analysts have recently increased price targets, resulting in a "Buy" consensus rating and an average target of $51.64 for AHR, which also declared a $0.25 quarterly dividend.
VIRGINIA RETIREMENT SYSTEMS ET Al Has $13.93 Million Holdings in American Healthcare REIT, Inc. $AHR
VIRGINIA RETIREMENT SYSTEMS ET Al has decreased its stake in American Healthcare REIT (AHR) by 7.8%, now holding 331,600 shares valued at $13.93 million. This comes as other major institutional investors like State Street, Invesco, and AllianceBernstein increased their positions in the company. American Healthcare REIT, with a market cap of $8.32 billion, has received a consensus "Buy" rating from Wall Street analysts and an average price target of $51.64.
American Healthcare REIT touts $590M in senior housing transactions this year
American Healthcare REIT (AHR) has significantly expanded its senior housing operating portfolio this year, completing $590 million in transactions and adding over 1,700 units across 14 properties. This contributes to a total of more than $950 million in acquisition activity for 2025, reflecting a strong commitment to investing in high-quality properties amidst growing demand for long-term care. AHR's strong performance, recognized in Nareit's report, positions it for continued growth in the new year.
American healthcare REIT completes over $950 million in acquisitions
American Healthcare REIT, Inc. (NYSE:AHR) has completed over $950 million in acquisitions in 2025, primarily focusing on its Integrated Senior Health Campuses and Senior Housing Operating Properties segments. The company, which offers a 2.1% dividend yield, plans to continue its acquisition strategy into 2026, targeting properties that align with its investment criteria and existing operating partners. These significant investments occurred alongside a recent public offering of 8.1 million shares and a raised price target from Truist Securities, reflecting a positive outlook despite a high P/E multiple.
American Healthcare REIT Announces Full-Year 2025 Acquisition Activity of Over $950 Million Across its Operating Portfolio
American Healthcare REIT, Inc. (NYSE: AHR) announced it completed over $950 million in new acquisitions during 2025, primarily focusing on its Integrated Senior Health Campuses (ISHC) and Senior Housing Operating Properties (SHOP) segments. This activity expands its operating portfolio, including a 14-property portfolio of long-term care assets and over 1,700 senior housing units, aligning with its strategy to invest in high-quality properties for the aging population. The company expects these acquisitions to drive strong risk-adjusted returns and plans to continue this growth momentum into the new year.
AHR - AMERICAN HEALTHCARE REIT INC Latest Stock News & Market Updates
This page provides the latest news and market updates for AMERICAN HEALTHCARE REIT (AHR), a real estate investment trust specializing in healthcare properties. It covers earnings reports, strategic acquisitions, public offerings, and other significant company developments, including its recent Q3 2025 results and increased full-year guidance. The platform serves as a resource for investors seeking timely and verified information on AHR's market position and operational strategies.
